PENICILLAMINE
PENICILLAMINE is indicated for the treatment of Wilson's Disease; Cystinuria; Rheumatoid Arthritis.
Details
- Status
- Prescription
- First Approved
- 2019-06-24
- Routes
- ORAL
- Dosage Forms
- CAPSULE, TABLET
Companies
PENICILLAMINE Approval History
What PENICILLAMINE Treats
3 indicationsPENICILLAMINE is approved for 3 conditions since its original approval in 2019. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Wilson's Disease
- Cystinuria
- Rheumatoid Arthritis
PENICILLAMINE Boxed Warning
Physicians planning to use penicillamine should thoroughly familiarize themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine should never be used casually. Each patient should remain constantly under the close supervision of the physician. Patients should be warned to report promptly any symptoms suggesting toxicity....
Physicians planning to use penicillamine should thoroughly familiarize themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine should never be used casually. Each patient should remain constantly under the close supervision of the physician. Patients should be warned to report promptly any symptoms suggesting toxicity.
PENICILLAMINE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in PENICILLAMINE's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications PENICILLAMINE treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to PENICILLAMINE
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PENICILLAMINE FDA Label Details
Indications & Usage
PENICILLAMINE is indicated for the treatment of Wilson's Disease; Cystinuria; Rheumatoid Arthritis.
Physicians planning to use penicillamine should thoroughly familiarize themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine should never be used casually. Each patient should remain constantly under the close supervision of the physician. Patients shou...
Looking for the branded version?
DEPEN
Full clinical data, patents, trials, and competitive landscape for penicillamine.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.